Some suggest that circulating insulin and androgens may have opposing effects on lipid profiles in patients with PCOS, particularly on the bioactive lipid metabolites derived from polyunsaturated fatty acids (Li et al., 2017). This evidence concerns the gene INS and polycystic ovary syndrome.